Genetic Technologies
GENE
$2.25
Share price
-6.25%
Change (1 day)
106.42%
Change (1 year)
Categories
Genetic Technologies (GENE) - Net assets
Net assets on the balance sheet as of June 2023 : $7.38 M
According to Genetic Technologies's latest financial reports the company has $7.38 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Genetic Technologies - Net assets on balance sheet (from 2004 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-06-30 | $7.38 M | -34.64% |
| 2022-06-30 | $11.3 M | -30.12% |
| 2021-06-30 | $16.17 M | 68.26% |
| 2020-06-30 | $9.61 M | 672.97% |
| 2019-06-30 | $1.24 M | -64.32% |
| 2018-06-30 | $3.48 M | -57.12% |
| 2017-06-30 | $8.13 M | -8.41% |
| 2016-06-30 | $8.87 M | -38.98% |
| 2015-06-30 | $14.54 M | 745.28% |
| 2014-06-30 | $1.72 M | -67.26% |
| 2013-06-30 | $5.25 M | -64.35% |
| 2012-06-30 | $14.74 M | 102.4% |
| 2011-06-30 | $7.28 M | 51.46% |
| 2010-06-30 | $4.81 M | -57.72% |
| 2009-06-30 | $11.37 M | -42.87% |
| 2008-06-30 | $19.91 M | -11.22% |
| 2007-06-30 | $22.43 M | 65.32% |
| 2006-06-30 | $13.56 M | -8.03% |
| 2005-06-30 | $14.75 M | 33.31% |
| 2004-06-30 | $11.06 M | 169.76% |
| 2003-06-30 | $4.1 M | -13.56% |
| 2002-06-30 | $4.74 M | -35.85% |
| 2001-06-30 | $7.39 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $46.84 B | 633,816.61% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $6.41 B | 86,755.32% | 🇺🇸 USA |
 Danaher DHR | $53.49 B | 723,784.54% | 🇺🇸 USA |
 LabCorp LH | $7.89 B | 106,682.78% | 🇺🇸 USA |
 Compugen CGEN | $65.55 M | 787.22% | 🇮🇱 Israel |
 Neogen NEOG | $3.14 B | 42,496.32% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.78 B | 10,499.11% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $2.23 M | -69.78% | 🇺🇸 USA |